Ftse Mib
34.664,36
-0,28%
DAX
18.677,87
-0,45%
S&P 500
5.298,82
-0,11%
NASDAQ
0,00
0,00%
Bitcoin
68.446,93
-1,36%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CNS Pharmaceuticals Inc (CNSP) CNS Pharmaceuticals Inc (CNSP) Notizie

CNS Pharmaceuticals Inc

CNSP
0,2098
0,0003 (0,14%)
Ultimo aggiornamento: 21:37:16
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/5/202416:56EDGAR2Form 8-K - Current report
15/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:28EDGAR2Form S-3 - Registration statement under Securities Act of..
07/5/202423:00EDGAR2Form 8-K - Current report
27/2/202423:15EDGAR2Form 8-K - Current report
21/2/202423:00EDGAR2Form 8-K - Current report
06/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:00EDGAR2Form 8-K - Current report
31/1/202422:27EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
23/1/202422:01EDGAR2Form 8-K - Current report
22/1/202412:02EDGAR2Form S-1/A - General form for registration of securities..
10/1/202423:26EDGAR2Form S-1/A - General form for registration of securities..
21/12/202315:15EDGAR2Form 8-K - Current report
18/12/202314:36EDGAR2Form 8-K - Current report
08/12/202323:28EDGAR2Form S-1 - General form for registration of securities under..
30/11/202323:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/11/202323:26EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202314:00EDGAR2Form 8-K - Current report
18/10/202315:00EDGAR2Form 8-K - Current report
17/10/202314:00EDGAR2Form 8-K - Current report
26/9/202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202323:25EDGAR2Form 8-K - Current report
15/8/202314:30EDGAR2Form 8-K - Current report
14/8/202323:12EDGAR2Form DEF 14A - Other definitive proxy statements
14/8/202315:25EDGAR2Form 8-K - Current report
14/8/202313:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 0,205 Min: 0,1971 Max: 0,219
Chiusura: 0,2095

La tua Cronologia

NASDAQ
CNSP
CNS Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network